2021 Fall Meeting: Immunity, Inflammation & Autoimmunity in Humans

The American Academy of Environmental Medicine (AAEM) is seeking presentations for the 56th Annual Fall Scientific Meeting. The 2021 conference will take place October 14 – 17, 2021 in San Diego, California at the DoubleTree by Hilton Mission Valley. Our focus will be on the unique challenges in immunity, inflammation and autoimmunity

Autoimmune diseases represent at least 80 illnesses that share a communal pathogenesis: an immune-mediated attack on the body’s own organs. As the human body reacts to its environment – including the diet – adverse reactions occur. The immune system may be provoked to create inflammatory consequences, which can damage any organ, tissue and cell. While pre-clinical and clinical research into these problems is expanding, standard treatments use symptom-suppressing drugs, rather than address the causes.

The associated cost of autoimmune disease has become a significant portion of the rising cost of US health care. This is because of a severe lack of awareness among the general public and medical practitioner and a lack of coordinated care and standardized diagnostic tests.

This conference will review the causes, mechanisms and consequences of the inflammatory effects of immune-mediated hypersensitivity, including post-viral and autoimmune illness. Our goals are to improve attendees’ understanding of the causes and effects of these conditions – and to improve their patients’ outcomes through preventative measures and providing optimal, causally-based treatment.

Call for Presentations


The American Academy of Environmental Medicine (AAEM) is seeking poresentations for the 56th Annual Fall Scientific Meeting. The 2021 conference will take place October 14 – 17, 2021 in San Diego, California at the DoubleTree by Hilton Mission Valley. Our focus will be on the unique challenges in immunity, inflammation and autoimmunity.

The AAEM has identified through various assessment tools that there is a strong need to education clinicians on the cuases, mechanisms, and consequences of the inflammatory consequences of immune-mediated hypersensitivity, including post-viral and autoimmune illness.

Autoimmune diseases represent at least 80 illnesses that share a communal pathogenesis: an immune-mediated attack on the body’s own organs. As the human body reacts to its environment – including the diet – adverse reactions occur. The immune system may be provoked to create inflammatory consequences, which can damage any organ, tissue and cell. While pre-clinical and clinical research into these problems is expanding, standard treatments use symptom-suppressing drugs, rather than address the causes. The associated cost of autoimmune disease has become a significant portion of the rising cost of US health care. This is because of a severe lack of awareness among the general public and medical practitioner and a lack of coordinated care and standardized diagnostic tests.
This conference will review the causes, mechanisms and consequences of the inflammatory effects of immune-mediated hypersensitivity, including post-viral and autoimmune illness. Our goals are to improve attendees’ understanding of the causes and effects of these conditions – and to improve their patients’ outcomes through preventative measures and providing optimal, causally-based treatment.

Presentations of 30 to 60 minutes should incorporate at least one of the following stated objectives.

The purpose of this conference is to empower health-care practitioners:

  • Better understanding of the distribution of these diseases through epidemiologic studies
  • Recognize the environmental triggers that contribute to the onset of these diseases
  • Develop effective prevention strategies that arrest the autoimmune process before it can irreversibly damage the body
  • Advance the training of health care practitioners so that we can effectively translate the advances in biomedical research to clinical practice.

Autoimmune diseases represent at least 80 illnesses that share a communal pathogenesis: an immune-mediated attack on the body’s own organs. According to the National Institute of Health (NIH), approximately 23.5 million Americans have an autoimmune disease. Studies indicate these diseases likely result from interactions between genetic and environmental factors. Gender, race, and ethnicity characteristics are linked to a likelihood of developing an autoimmune disease.

Autoimmune diseases are more common when people are in contact with certain environmental exposures. As the human body reacts to its environment – including the diet – adverse reactions occur. The immune system may be provoked to create inflammatory consequences, which can damage any organ, tissue and cell. While pre-clinical and clinical research into these problems is expanding, standard treatments use symptom-suppressing drugs, rather than address the causes.

The associated cost of autoimmune disease has become a significant portion of the rising cost of US health care. This is because of a severe lack of awareness among the general public and medical practitioners and a lack of coordinated care and standardized diagnostic tests. According to the National Institutes of Health (NIH), the estimated annual direct health care costs for autoimmune disease are near to the $100 billion. Whereas for cancers, and heart & strokes, the cost is around $57 billion, and $200 billion, respectively.

REFERENCES:

  1. NIH Autoimmune Diseases Coordinating Committee: Progress in Autoimmune Diseases Research, March 2005. (Last accessed December 14, 2020)
  2. Ramos PS, Shedlock AM, Langefeld, CD. 2015. Genetics of autoimmune diseases: insights from population genetics. J Hum Genet. 60(11): 657–664.
  3. “The Cost Burden of Autoimmune Disease: the Latest Front in the War on Healthcare Spending,” American Autoimmune Related Diseases Association and National Coalition of Autoimmune Patient Groups, 2011; AARDA INFOCUS, Vol. 19, No. 2, June 2011

asic and clinical medical science research, clinical outcome studies, meta-analyses, documented case presentations and clinically useful insights concerning the diagnosis and treatment of inflammatory and autoimmune diseases

The role of microorganisms in inflammation and autoimmunity; e.g. post-viral cardiomyopathy, inflammatory bowel etc.

Inflammation and autoimmunity in the GI tract related to foods; e.g. gluten sensitivity, Heiner syndrome etc.

Inflammation and autoimmunity caused by environmental substances; e.g., organic inhalants, chemicals, etc.

Aging, inflammation and autoimmunity

Basic pathways and biochemistry of autoimmune dysfunction

Modulating the immune system to prevent and treat inflammation and autoimmunity

New information about immune-mediated diseases, including:

  • Graves and Hashimoto thyroiditis
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Premature ovarian insufficiency
  • Type-1 diabetes
  • Myasthenia gravis
  • Scleroderma
  • Primary biliary cirrhosis
  • Addison’s disease
  • Idiopathic hypoparathyroidism
  • Autoimmune hemolytic anemia
  • Otosclerosis and Meniere’s syndrome
  • Goodpasture’s syndrome and others

The focus areas for this conference were developed by the Meeting Planning Committee and the Executive Committee of the AAEM based on feedback from participants in prior AAEM conferences; data collected from clinicians who completed the AAEM Needs Assessment Survey; literature review and documentation of increased demand for environmental medicine education for health care professionals, as clearly demonstrated by the success of the previous conferences.

We welcome practitioners of all specialties and backgrounds who care for patients with these disorders and academicians whose research enhances our understanding. We particularly invite professionals who are eligible for Fellow-membership in the AAEM, whose credentials may be MD, DO, ND, DC, PhD, PharmD, DMD/ DDS; Nurse-Practitioners, Physician-Assistants and their international equivalents.

MONDAY, MARCH 15, 2021— Submission Deadline

MONDAY, APRIL 19, 2021 — Selected session presenters notified

MONDAY, AUGUST 30, 2021 — Presentations must be reviewed and approved by CME Planning Committee (Email presentation to [email protected]). Changes may not be made to content, presenters, or slides after review.

OCTOBER 14 – 17, 2021 — Live presentations

Authors should keep in mind that all presentations must be evidence- or clinical observation- based, show references/citations, and provide a balanced view of any protocols. Include the “Level of Evidence” (A, B, C) or “Strength of Recommendation” (A, B, C) in your footnotes and bibliography if at all possible. Even when not advocating mainstream options for treatment, please include mainstream treatment options in your presentation for comparison to the treatment being recommended. This is being required to satisfy ACCME standards for valid clinical content.

Each diagnostic or treatment presentation must provide “how-to” guidelines that attendees may take home and implement in their practices, unless special training is required, in which case, that information should be provided.

You will need to list three (3) session objectives in your proposal, so please have that information prepared prior to your submission. AAEM’s 2021 Conference Objectives are listed below, and the information submitted in your proposal should address at least one of the objectives to help set the stage for AAEM’s 2021 Annual Fall Meeting. Please ensure that your presentation is unique to AAEM’s conference; and is not given to another organization or event at least two (2) months before/after AAEM’s scheduled annual meeting dates (October 14 – 17, 2021).

OBJECTIVES: At the end of this presentation attendees will be able to….

  • Better understanding of the distribution of these diseases through epidemiologic studies
  • Recognize the environmental triggers that contribute to the onset of these diseases
  • Develop effective prevention strategies that arrest the autoimmune process before it can irreversibly damage the body
  • Advance the training of health care practitioners so that we can effectively translate the advances in biomedical research to clinical practice.

All information received, especially your abstract and bio, should be proofed for spelling and grammatical errors. Your submission will be reviewed by AAEM’s Planning Committee UNALTERED (typographical errors will not be corrected)

AAEM reserves the right to edit titles and content of your abstract submission. Information you should prepare includes:

  • Submit an abstract of your proposed presentation (not to exceed 250 words), including 2-3 references that provide the best evidence underlying your proposed talk.
  • Submit 3 specific learning objectives for the attendees (e.g., At the end of this presentation attendees will be able to….)
  • Provide a brief biography for EACH Presenter (limited to 250 words written in paragraph format) to be posted on the conference website (do not compose in the 1st person tense or list hobbies and/or person family comments).
  • Provide a digital photo for use in promoting your presentation.

Abstract Submission Form



  • *not to exceed 250 words. Include 2-3 references that provide the best evidence underlying your proposed talk.


  • Learning Objectives

    Please identify three learning objectives that the participants will be able to improve upon or achieve after attending your session.


  • Teaching Methods


  • ACGME and IOM Competencies

    Please indicate which of the competencies below that you will be addressing in your presentation:


  • Biography


  • Disclosures


  • Important: Please check all your entries before clicking Submit

Interested in Becoming an AAEM Member?

Apply Here